Notch1 phenotype and clinical stage progression in non-small cell lung cancer

被引：0
|
作者：
Dat Nguyen
Larry Rubinstein
Naoko Takebe
Lucio Miele
Joseph E Tomaszewski
Percy Ivy
James H Doroshow
Sherry X Yang
机构：
[1] National Clinical Target Validation Laboratory,Stanley Scott Cancer Center
[2] Division of Cancer Treatment and Diagnosis,undefined
[3] National Cancer Institute,undefined
[4] National Institutes of Health,undefined
[5] Biometric Research Branch,undefined
[6] Division of Cancer Treatment and Diagnosis,undefined
[7] National Cancer Institute,undefined
[8] National Institutes of Health,undefined
[9] Cancer Therapy Evaluation Program,undefined
[10] Division of Cancer Treatment and Diagnosis,undefined
[11] National Cancer Institute,undefined
[12] National Institutes of Health,undefined
[13] Louisiana State University Health Sciences Center and Louisiana Cancer Research Consortium,undefined
[14] Division of Cancer Treatment and Diagnosis,undefined
[15] National Cancer Institute,undefined
[16] National Institutes of Health,undefined
来源：
Journal of Hematology & Oncology | / 8卷
关键词：
Lung cancer; N1-ICD; Notch1; NSCLC; Stage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Notch1 phenotype and clinical stage progression in non-small cell lung cancer
    Dat Nguyen
    Rubinstein, Larry
    Takebe, Naoko
    Miele, Lucio
    Tomaszewski, Joseph E.
    Ivy, Percy
    Doroshow, James H.
    Yang, Sherry X.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [2] Association of Notch-1 phenotype with clinical stage progression in non-small cell lung cancer
    Yang, Sherry X.
    Rubinstein, Larry
    Dat Nguyen
    Tomaszewski, Joseph E.
    Takebe, Naoko
    Ivy, Percy
    Doroshow, James H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] An alternative way to initiate Notch1 signaling in non-small cell lung cancer
    Yang, Yi-Lin
    Jablons, David
    You, Liang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (04) : 238 - 241
  • [4] Expression of notch1, numb, and musashi1 in non-small cell lung cancer
    Kikuchi, Hajime
    Sakakibara-Konishi, Jun
    Lkezawa, Yasuyuki
    Takashina, Taichi
    Mizugaki, Hidenori
    Kikuchi, Eiki
    Kikuchi, Junko
    Shinagawa, Naofumi
    Oizumi, Satoshi
    Hida, Yasuhiro
    Kaga, Kichizo
    Kinoshita, Lchiro
    Dosaka-Akita, Hirotoshi
    Nishimura, Masaharu
    CANCER RESEARCH, 2016, 76
  • [5] NOTCH 1 and NOTCH 3 expressions for early stage of non-small cell lung cancer
    Cho, Eun Kyung
    Lee, Jae Hoon
    Ha, Seung Yeon
    Park, Sanghui
    Lee, Jae-ik
    Hong, Junshik
    Jung, Minkyu
    Sym, Sun Jin
    Park, Jinny
    Shin, Dong Bok
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [6] NOTCH 1 and NOTCH 3 expressions for early stage of non-small cell lung cancer
    Cho, Eun Kyung
    Ha, Seung Yeon
    Lee, Jae Ik
    Hong, Junsick
    Sim, Sun Jin
    Park, Jinny
    Shin, Dong Bok
    Lee, Jae Hoon
    CANCER RESEARCH, 2015, 75 (22)
  • [7] NOTCH 1 and NOTCH 3 Expressions for Early Stage of Non-Small Cell Lung Cancer
    Cho, E. K.
    Ha, S. Y.
    Lee, J.
    Kyung, S. Y.
    Kang, S. M.
    Ahn, H. K.
    Kim, Y. J.
    Park, J. W.
    Jung, S. H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2294 - S2294
  • [8] EXPRESSION OF Notch1, HIF-1, VEGF AND Notch1 mRNA IN HUMAN NON-SMALL CELL LUNG CANCER AND ITS SIGNIFICANCE
    Zhou, Jian Hua
    Jiang, Xin
    Deng, Zheng Hao
    Qu, Xiao Hui
    Yang, Xiao Jing
    Jiang, Hai Ying
    CELL BIOLOGY INTERNATIONAL, 2008, 32 (03) : S39 - S40
  • [9] NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Huang, Qingyuan
    Cao, Hang
    Yao, Qianlan
    Zhou, Xiaoyan
    Li, Hang
    Bai, Qianming
    Hu, Hong
    IMMUNOTARGETS AND THERAPY, 2023, 12 : 165 - 173
  • [10] Notch 1 and Notch 3 and prognosis of resected non-small cell lung cancer
    Cho, E.
    Ha, S.
    Park, S.
    Lee, J.
    Park, J.
    Jung, S.
    Sym, S.
    Shin, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345